Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer
Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Objective: The aim of this study was to evaluate disease-specific survival and cost related to radioactive iodine therapy (RAI) utilization in patients with early-stage papillary thyroid carcinoma (PTC). Methods: This was a retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database, 2004-2012. Results: A total...
Alternative Titles
Full title
Financial Implication of Radioactive Iodine Therapy for Early-Stage Papillary Thyroid Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_28609768
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_28609768
Other Identifiers
ISSN
0030-2414,1423-0232
E-ISSN
1423-0232
DOI
10.1159/000466700
